"Located in Olney, MD, MedStar Montgomery Medical Center has become a cornerstone of the community. Offering health and wellness classes, community lectures, free screenings, blood pressure checks, and more. We're your partner not just in sickness, but also in health. Our unique services include bariatric surgery and weight loss management, cancer care, orthopedics, neuroscience, and women's health. From preconception planning and genetic counseling, to labor and delivery, our OBGYN providers are here for women through every stage of life. For expecting parents, we offer a wide variety of childbirth and planning classes."

During the past decade, Medstar Montgomery Medical Center conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 13 clinical trials were completed. i.e. 650% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medstar Montgomery Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 10 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Dendreon" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medstar Montgomery Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Medstar Montgomery Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Breast Carcinoma" (2 trials), "Prostate Cancer" (2 trials) and "Recurrent Breast Carcinoma" (2 trials). Many other conditions were trialed in "Medstar Montgomery Medical Center" in a lesser frequency.

Most popular intervention types in "Medstar Montgomery Medical Center" are "Drug" (17 trials), "Other" (15 trials), "Biological" (5 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Docetaxel" (3 trials), "Quality-of-Life Assessment" (3 trials), "Durvalumab" (2 trials) and "Exemestane" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medstar Montgomery Medical Center" are 19 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Medstar Montgomery Medical Center". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Medstar Montgomery Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medstar Montgomery Medical Center, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".